Spots Global Cancer Trial Database for analysis of complement activation pathways prior to, during and
Every month we try and update this database with for analysis of complement activation pathways prior to, during and cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia | NCT00892827 | Advanced Refrac... | Rituximab (Mabt... | 18 Years - | Wolfson Medical Center |